![]() |
|
|
Vol. 289, Issue 1, 14-23, April 1999
Department of Psychiatry, Case Western Reserve University, and
Cleveland Veterans Affairs Medical Center, Brecksville, Ohio
Research has shown that there are important neurochemical differences
between the mesocortical and mesostriatal dopamine systems. The work
reported in this paper has sought to compare the regulation of dopamine
release in the medial prefrontal cortex and the anterior caudate-putamen. In vivo microdialysis was used to recover dialysate fluid for subsequent assay for dopamine concentrations. The responses to D2 antagonist (haloperidol) administration, which has been shown to
increase impulse-dependent dopamine release, were compared. Results
demonstrated a diminished effect of systemic haloperidol administration
on dopamine efflux in the prefrontal cortex. The responses to systemic
administration of a nonimpulse-dependent, transporter-mediated,
dopamine releaser (d-amphetamine) were also contrasted.
Results again demonstrated a diminished pharmacological effect in the
cortex. The potential interaction of stimulation of these two types of
dopamine release was examined by coadministration of these compounds.
Haloperidol pretreatment dramatically potentiated the
dopamine-releasing effect of amphetamine administration. This effect
was observed in both the cortex and the striatum. Subsequent work
demonstrated that this effect of haloperidol was mediated by D2-like
receptors in the prefrontal cortex. These results are discussed in
relation to other neurochemical and neuroanatomical studies
demonstrating sparse densities of dopamine transporter sites and
dopamine D2 receptors in the cortex compared with the striatum. They
demonstrate a functional correlate to the recently reported, largely
extrasynaptic localization of dopamine transporter sites in the
prefrontal cortex. Furthermore, they demonstrate the existence of
cortical D2-like autoreceptors that may normally be "silent" under
basal conditions.
This article has been cited by other articles:
![]() |
G. Grunder, C. Fellows, H. Janouschek, T. Veselinovic, C. Boy, A. Brocheler, K. M. Kirschbaum, S. Hellmann, K. M. Spreckelmeyer, C. Hiemke, et al. Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study Am J Psychiatry, August 1, 2008; 165(8): 988 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Lee, J.-H. Hong, I. Y. Choi, Y. Che, J.-K. Lee, S.-D. Yang, C.-W. Song, H. S. Kang, J.-H. Lee, J. S. Noh, et al. Impaired D2 Dopamine Receptor Function in Mice Lacking Type 5 Adenylyl Cyclase J. Neurosci., September 15, 2002; 22(18): 7931 - 7940. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Wayment, J. O. Schenk, and B. A. Sorg Characterization of Extracellular Dopamine Clearance in the Medial Prefrontal Cortex: Role of Monoamine Uptake and Monoamine Oxidase Inhibition J. Neurosci., January 1, 2001; 21(1): 35 - 44. [Abstract] [Full Text] [PDF] |
||||